Opinion

Video

A 62-Year-Old Man With High-Risk Localized Prostate Cancer

A panelist discusses how a 62-year-old man with high-risk localized prostate cancer was treated with intensified therapy, including abiraterone plus radiation, but experienced tolerability issues with the traditional fasting formulation.

Managing Comorbidities and Drug Interactions

This segment addresses the complex management of patients with metastatic castration-resistant prostate cancer who have multiple comorbidities, particularly focusing on diabetes and liver disease considerations. Patients with diabetes and their health care providers often express concern about the steroid component (prednisone or prednisolone) required with abiraterone therapy, fearing disruption of glucose control. The segment explains that these steroids primarily serve to replace mineralocorticoids suppressed by abiraterone rather than providing excess steroid exposure.

Regular monitoring becomes essential for patients with comorbidities, including frequent blood glucose checks for diabetics and liver function monitoring for all patients on abiraterone. Although hepatotoxicity remains relatively rare with abiraterone therapy, systematic monitoring allows for early detection and management of potential complications. The discussion emphasizes the importance of coordinated care between oncology, primary care, and specialty providers to ensure comprehensive patient management.

When patients experience tolerability issues with traditional abiraterone formulations, documented inability to comply with fasting requirements provides justification for switching to microformulation alternatives. This approach ensures that treatment decisions are based on objective clinical assessments rather than subjective preferences, supporting both optimal patient outcomes and appropriate insurance coverage considerations.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
© 2025 MJH Life Sciences

All rights reserved.